Arvest Bank Trust Division

Bank

Position in NVS — Novartis AG

CIK 1625959 DEWEY, OK

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$915,871

-$27,513 QoQ

Shares Held

5,844

-5.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#650

of 1,603 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arvest Bank Trust Division holds $45,815,739 across 8 Drug Manufacturers - General names. NVS ranks #6 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	60,049	$15,110,729
2	JNJ	Johnson & Johnson	57,057	$14,490,765
3	LLY	ELI LILLY & Co	9,403	$11,278,240
4	MRK	Merck & Co., Inc.	14,386	$1,848,601
5	PFE	Pfizer Inc	48,596	$1,170,191
6	NVS	Novartis AG This page	5,844	$915,871
7	BMY	Bristol Myers Squibb Co	12,969	$747,273
8	GILD	Gilead Sciences, Inc.	2,011	$254,069

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$915,871	5,844	-5.4%	Shares	Sole	2026-08-13
2026-03-31	$943,384	6,176	+7.9%	Shares	Sole	2026-05-13
2025-12-31	$788,892	5,722	-3.9%	Shares	Sole	2026-02-09
2025-09-30	$763,925	5,957	-4.2%	Shares	Sole	2025-11-07
2025-06-30	$752,319	6,217	-71.3%	Shares	Sole	2025-08-08
2025-03-31	$2,412,650	21,642	-3.3%	Shares	Sole	2025-05-14
2024-12-31	$2,177,700	22,379	-3.7%	Shares	Sole	2025-02-13
2024-09-30	$2,673,754	23,246	+107.8%	Shares	Sole	2024-11-25
2021-09-30	$914,709	11,185	+24.5%	Shares	Sole	2021-11-12
2021-06-30	$819,608	8,983	+8.5%	Shares	Sole	2021-08-19
2021-03-31	$707,432	8,276	+23.1%	Shares	Sole	2021-04-13
2020-12-31	$634,852	6,723	+29.1%	Shares	Sole	2021-02-17
2020-09-30	$452,800	5,207	+109.6%	Shares	Sole	2020-11-30
2020-06-30	$216,952	2,484	—	Shares	Sole	2020-08-21
No filing history on record for this holder in this stock.